Printer Friendly

Articles from M2 Pharma (November 3, 2017)

1-33 out of 33 article(s)
Title Author Type Words
AbbVie's Elagolix indicates decreased pelvic pain in two replicate Phase three extension studies. 191
Akros Pharma Extends 10-year Partnership with Medidata. 203
Amgen, Novartis & the Banner Alzheimer's Institute (BAI) partnership to determine whether the BACE1 inhibitor CNP520 can prevent or delay the onset of Alzheimer's disease symptoms. 308
AstraZeneca Selects Biologics to Distribute Calquence. 212
Bacteria in our gut found to influence tumours during cancer therapy. 217
Bexion Pharmaceuticals Commences Phase 1b Clinical Trial of BXQ-350 in Patients with Advanced Solid Tumors. 265
Biogen Presents New Data from Long-Term Extension of Phase 1b Study of Investigational Alzheimer's Disease Treatment Aducanumab. 777
Boehringer Ingelheim and Dicerna collaborating on development of RNAi therapeutics for liver disease. 228
BrainStorm names Eyal Rubin as CFO. 140 Adds Dan Yoo to Board of Directors. 351
Concentric Analgesics Begins Clinical Trial of CA-008 for Post-Surgical Pain Following Bunionectomy. 198
Constellation Pharmaceuticals names new chief financial officer and senior vice president, corporate development. 162
Eleven Biotherapeutics Anticipates Proceeds of Underwritten Public Offering of USD 8m. 386
ENDEAR Study Results of Spinraza for the Treatment of SMA Published in NEMJ. Clinical report 212
Gallagher Named Editor in Chief of Contagion. 244
GlaxoSmithKline indicates Anoro Ellipta to be more effective than Stiolto Respimat in improving lung function. 187
Hydra Biosciences and Boehringer Ingelheim Collaboration Initiates Clinical Trial of TRPC4/5 Inhibitor for CNS Disorders. 244
Medivir names Erik BjA[pilcrow sign]rk as new CFO. 129
Medytox and Allergan give update on phase III trial for Innotox. 210
Novartis and Amgen expand Banner Alzheimer's Institute collaboration for new prevention study. 247
Novartis confirms that it will buy Advanced Accelerator Applications. 185
Novartis submits supplemental Biologics License Application for Kymriah to US Food and Drug Administration. 187
Oncolytics Biotech hires Deborah Brown to board. 154
RaySearch Laboratories' RayStation selected for Provision CARES Proton Therapy Centre in Franklin, US. 279
RayStation selected as treatment planning system for CYCLHAD Hadrontherapy Centre, France. 216
scPharmaceuticals submits Furoscix (subcutaneous furosemide) NDA with US FDA. 136
Seattle Genetics Files sBLA to FDA for Adcetris for Treatment of Hodgkin Lymphoma. 310
SMA Type 1 Patients Receiving Single Dose of AveXis Gene Replacement Therapy are Alive and Event-free at 20 Months of Age. 400
UK government to speed up approvals for five innovative medicines a year. 213
Valeant Pharmaceuticals wins US approval for VYZULTA NDA for intraocular pressure. 247
WuXi Biologics partners with Pall Corporation for establishment of continuous bioprocess laboratory. 237
Xenetic Grants Baxalta Right to Sublicense PolyXen Technology. 185
Zealand posts royalty revenues of DKK10.4m in Q3 2017. Financial report 292

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |